Hyaluronan turnover in hyaluronidase 3- and β-hexosaminidase-deficient mice
| dc.contributor.author | Arja, Vasantha | |
| dc.contributor.examiningcommittee | Merz, David (Biochemistry and Medical Genetics) Wrogemann, Klaus (Biochemistry and Medical Genetics) Anderson, Judith (Biological Sciences) Srinivasan, Ganesh (Pediatrics adn Child Health) de la Motte, Carol (Pathobiology, Cleveland Clinic, USA) | en |
| dc.contributor.supervisor | Triggs-Raine, Barbara (Biochemistry and Medical Genetics) | en |
| dc.date.accessioned | 2010-04-08T17:25:36Z | |
| dc.date.available | 2010-04-08T17:25:36Z | |
| dc.date.issued | 2010-04-08T17:25:36Z | |
| dc.degree.discipline | Biochemistry and Medical Genetics | en_US |
| dc.degree.level | Doctor of Philosophy (Ph.D.) | en_US |
| dc.description.abstract | Hyaluronan (HA) is a glycosaminoglycan that is abundant in the extracellular matrix of vertebrate cells. Under physiological conditions HA exists in a high-molecular-weight form, whereas HA fragments accumulate at sites of tissue injury and inflammation. Hyaluronidases are a group of enzymes that initiate the breakdown of HA. In humans, six hyaluronidase-like sequences have been identified in two locations, 3p21.3 (HYAL1, HYAL2 and HYAL3) and 7q31.3 (HYAL4, SPAM1 and HYALP1). Deficiency of one of these enzymes, HYAL1, was identified in a patient with Mucopolysaccharidosis IX, a disorder characterized by peri-articular soft masses containing HA-filled lysosomes. Given the broad distribution of HA and the mild phenotype of the patient, it is likely that other hyaluronidases or possibly the exoglycosidases, β-hexosaminidase and β-glucuronidase, are playing a major role in HA degradation. To address the potential role of HYAL3 in HA degradation in health and disease, a Hyal3-deficient mouse model was generated. Hyal3-deficient mice were viable, fertile and appeared to have no gross phenotype. The only difference observed was a subtle change in the cellularity and tissue structure of lungs from aged Hyal3-deficient mice. Further studies focused on analysis of HA homeostasis revealed a significant increase in HA in the airways of Hyal3-deficient lungs. Altered HA homeostasis is observed in rodent models of several lung conditions. In order to further study the role of Hyal3 in lungs, an ovalbumin-challenged inflammation model was generated in Hyal3-deficient mice. A significant increase in lung HA levels and altered distribution of HA in the airways of lungs was detected in ovalbumin-challenged Hyal3-deficient mice. Moreover, lung inflammation and airway resistance were increased in Hyal3-deficient mice after ovalbumin-challenge compared to similarly treated Hyal3-control mice. This suggests HA homeostasis that is altered during Hyal3-deficiency might be directly or indirectly promoting inflammation and airway resistance. Because the reported level of HA accumulation was very low in Hyal1-deficient and Hyal2-deficient mice, and in our studies of Hyal3-deficient mice, we performed preliminary studies to assess a role for an exoglycosidase, β-hexosaminidase, in HA turnover. Our preliminary studies indicate there is no or little HA accumulation in β-hexosaminidase-deficient mouse tissues. To conclude, our study of Hyal3- and β-hexosaminidase-deficient mice suggests that these are not the major enzymes involved in HA degradation | en |
| dc.description.note | May 2010 | en |
| dc.format.extent | 6017634 bytes | |
| dc.format.mimetype | application/pdf | |
| dc.identifier.citation | Atmuri, Vasantha (2008). Hyaluronidase 3 (HYAL3) knockout mice do not display evidence of hyaluronan accumulation, Matrix Biology 27:653-60 | en |
| dc.identifier.uri | http://hdl.handle.net/1993/3917 | |
| dc.language.iso | eng | en_US |
| dc.rights | open access | en_US |
| dc.subject | hyaluronan | en |
| dc.subject | hyaluronidase | en |
| dc.title | Hyaluronan turnover in hyaluronidase 3- and β-hexosaminidase-deficient mice | en |
| dc.type | doctoral thesis | en_US |